Alnylam Pharma (ALNY) Posts Smaller-than-Expected Q1 Loss

Go back to Alnylam Pharma (ALNY) Posts Smaller-than-Expected Q1 Loss

Alnylam Pharmaceuticals (ALNY) PT Lowered to $116 at Evercore ISI

May 4, 2018 7:51 AM EDT

Evercore ISI lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $116.00 (from $118.00) while maintaining a In Line rating.

... More